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Objectives: The aim of this study was to determine the prevalence and associated factors
of inconsistent condom use among Iranian male injecting drug users (IDUs).
Materials and Methods: Data came from the national Iranian behavioral survey of drug
dependence, which sampled 7743 individuals with drug dependence, from medical cen-
ters, prisons, and streets in 29 provinces in Iran, in 2007.This study included all individuals
who were male, IDUs, and were sexually active (n=1131). The main outcome was incon-
sistent condom use which was assessed using a single item. A logistic regression was
used to determine the association between socio-economic data, drug use data, and high
risk injection behaviors with inconsistent condom use.
Result: 83.3% of sexually active IDUs (n=965) reported inconsistent condom use. Based
on the logistic regression, likelihood of inconsistent condom use was higher among those
with a history of syringe sharing [Odds Ratio (OR); 1.63, 95% Confidence Interval (CI); 1.13–
2.34], but lower among those with higher education levels (OR; 0.34, 95% CI; 0.14–0.82),
those who mostly inject at home (OR; 0.09, 95% CI; 0.02–0.47), and those with a history
of treatment (OR; 0.54, 95% CI; 0.31–0.94).
Conclusion: Because of the link between unsafe sex and risky injecting behaviors among
Iranian IDUs, combined programs targeting both sexual and injection behavior may be more
appropriate than programs that target sexual or injection behavior.The efficacy of combined
programs should be, however, compared with traditional programs that only target sexual
or injection behavior of IDUs.
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INTRODUCTION
With a population of 68 million, Iran has the highest per capita
opiate consumption rate in the world (1). The Iranian Ministry of
Health, Treatment and Medical Education has recently announced
an estimated figure of 200,000 injecting drug users (IDUs) in Iran
(2). It is believed that most Iranian IDUs are male, single and in
the age range of 20–39 years old with more than 70% having a his-
tory of imprisonment and a history of addiction treatment. Most
Iranian IDUs inject opioids, heroin, and crack (3).
Although Iran has a number of harm reduction programs for
tackling HIV, HBV, and HCV epidemics among IDUs, prevalence
of HCV and HIV infections in IDUs are still high. According to
one study, 65.9 and 18.8% of Iranian IDUs are infected with HCV
and HIV/AIDS infections, respectively (3). It is believed that IDUs
account for 62% of new cases of HIV/AIDS in Iran (4). A qualita-
tive study of HIV risk behaviors in Iran showed drug-related harm
in almost all study locations. The study reported a prevalence of
sharing injection instruments ranging from 30 to 100%. The study
concluded that drug injection in Iran is strongly associated with
HIV risk, and sharing injection instruments is a common behavior
among Iranian IDUs (5). Other studies have also shown high rates
of HIV risk behaviors among Iranian IDUs (6–12).
Designing condom promotion programs needs research based
information on rate and determinants of inconsistent condom use
among high risk populations (13). Such information is believed
to have emerging public health implications (14) by increasing the
efficacy of programs that target HIV transmission through sexual
behaviors.
Policy makers and program planners have shown an increas-
ing interest on epidemiology of condom use among the general
population (15), people with sexually transmitted infections (16),
HIV positive patients (17), sex workers (18), drug users (19), and
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IDUs (20). Most IDUs are known to be sexually active and engage
in high risk sexual behaviors that facilitate HIV transmission from
IDUs to the general population (21).
As most previous reports on risk profile of Iranian IDUs have
mainly or exclusively focused on injecting behaviors (5–7, 10–12,
22), we aimed to investigate the prevalence and associated fac-
tors of inconsistent condom use among a nationwide sample of
sexually active Iranian male IDUs.
MATERIALS AND METHODS
DESIGN AND SETTING
Data came from a national behavioral survey of drug dependence,
which sampled adults with drug dependence disorder (according
to the Diagnostic and Statistical Manual of Mental Disorders –
IV) from 29 provinces in 2007. This study was conducted under
the financial aid of the Drugs Control Headquarters. Some other
reports have been extracted from this database (6, 23–27).
The study was approved by the ethical review committee of the
University of Social Welfare and Rehabilitation Sciences. Informed
consent was obtained from all the participants after they had been
verbally reassured that the information would be kept confidential.
SAMPLING OF MAIN SURVEY
Participants of the main survey were sampled from treatment cen-
ters (n= 1217), prisons (n= 584), and streets (n= 5860) of the
capitals of 29 provinces in the Islamic Republic of Iran. In 82 (1%)
individuals, setting was missing. The samples from treatment cen-
ters were selected with a simple random strategy from newcomers,
using computer generated random numbers. Prisoners were also
sampled randomly from those who were registered into the prison
within the previous month. The snowball approach was used to
take samples from streets. The number of samples taken from
every province was proportional to the whole population of the
province. This sampling strategy has been used as the main sam-
pling strategy of drug dependence disorder surveys. The study
used age, sex, marital status, and drug use data as a strategy to
check if all individuals were different. Participants did not have
identical data in these regards.
PARTICIPANTS ENROLLED TO THIS ANALYSIS
Although the mother study had sampled 7743 individuals, as most
participants were not IDUs,only 1131 male current IDUs who were
sexually active enrolled in this study. One hundred and sixty-seven
(14.8) were selected from treatment centers, 846 (74.9%) were
selected from streets, and 89 (7.9) were selected from prisons. In
2.4%, setting was missing. From 7743, 2091 (27%) were males who
had positive history of intravenous injection. From this number,
only 1131 (54%) participants’ current and main mode of drug use
was injection. We only enrolled men in this analysis because<5%
of IDUs were female.
PROCESS
Data collection started in April 2007 and lasted for 5 months. The
interviews were carried out by university graduates with drug use
research interest who were dispatched to the provinces after being
trained through workshops in Tehran (the capital of Iran). Each
interview took between 60 and 90 min. Data were collected using
a paper-based questionnaire that was the modified version of the
one used in the previous national drug dependence survey of Iran.
Sixty nine items were classified in nine different parts including:
(1) socio-economic data (at the time of data collection), (2) family
data, (3) first use data, (4) lifetime drug use, (5) current drug of
dependency, (6) injection data, (7) high risk behavior, (8) treat-
ment data, and (9) social network. The questionnaire is available
online (23).
Independent variables in the current study included socio-
economic data (at the time of data collection), family data, first
use data, injection data, high risk behavior data, and treatment
data. Some of the variables included age, gender, educational level,
marital status, living condition, homelessness, employment status,
income, sources of income, family history of substance use, first
place of drug use, first situation of drug use, person who suggested
drug use, common place of injection, history of treatment, syringe
sharing, history of arrest, and imprisonment.
To make the final costs internationally comparable, drug costs
were presented in purchase power parity or international Dollar
(PPP$). The conversion rate for PPP$ was equal to 2727 Rials
according to the World Bank database (28).
OUTCOME
The main outcome was inconsistent condom use, asked by the
following question: how often do you use condoms? Answers
included: (1) often, (2) half the times, (3) less than half of the
times, and (4) seldom, and (5) never. A single item five-point scale
has been previously used for condom use (29, 30). We considered
inconsistent condom use as any answer except often. Although
some researchers believe that self-reported condom use may have
limited accuracy (31), high reproducibility and validity has also
been reported (32, 33).
STATISTICAL ANALYSIS
The data were analyzed using Statistical Package for the Social
Sciences (SPSS) for Windows 13. First, we checked the normality
of numerical data; with the use of a One-Sample Kolmogorov–
Smirnov test. In order to present numerical data with a normal
distribution, we used mean and standard deviation (SD) and for
data with skewed distribution, we presented the median, and the
first and third quartiles. In order to compare categorical variables
between those with and without“inconsistent condom use,”a Chi-
square test was used. The comparison of age between the two
groups was done with a t -test, and the comparison of monthly
family income and expenditures of drug use between two groups
was done with a Mann–Whitney. Multivariate stepwise logistic
regression was applied to determine the associated factors of
inconsistent condom use. We used backwards elimination for
our regression analysis. All variables with a significant associa-
tion with inconsistent condom use in bivariate analysis were put
into the stepwise model. The Odds Ratio (OR) and 95% Confi-
dence Interval (CI) were reported. p-value <0.05 was considered
significant.
RESULTS
All participants were male, with mean (SD) ages at study, at first
drug use and at first injection being 31.3± 8.3, 18.6± 5.4, and
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Education level Illiterate or were barely able
to read and write
105 90.5 0.001
Primary school to diploma 783 83.6
Upper diploma 54 70.1
Marital status Single 496 82.4 0.047
Married 293 81.8
Separate, divorce, and widow 170 89.5
Being homeless No 790 82.3 0.016
Yes 137 90.1
Living alone No 778 82.3 0.053
Yes 187 87.8
Jobless No 548 80.8 0.007
Yes 417 86.9
Drug income No 654 81.2 0.007
Yes 294 87.8
Job income No 462 85.6 0.040
Yes 486 81.0
Illegal income No 604 80.9 0.004
Yes 344 87.5
*Chi-square.
25.9± 6.7 years, respectively. Most participants were Muslim, lived
in urban areas, and had not completed high school (Data not
shown).
OUTCOME
Out of 1131 sexually active IDUs, 965 (83.3%) reported inconsis-
tent condom use.
ASSOCIATES OF INCONSISTENT CONDOM USE
Inconsistent condom use was not associated with age at study, age
at first drug use, or age at first injection. IDUs with inconsistent
condom use had a lower monthly income (median: 200, first quar-
tile: 110, third quartile: 350 vs. median: 250, first quartile: 150, third
quartile: 400, p= 0.001) and lower median monthly money paid
for drugs (median: 150, first quartile: 100, third quartile: 270 vs.
median: 200, first quartile: 120, third quartile: 350, p< 0.001). The
association between inconsistent condom use and socio-economic
variables are presented in Table 1.
Inconsistent condom use was higher among IDUs whose dom-
inant drug was heroin in comparison to IDUs that had a dif-
ferent dominant drug (86.3 vs. 81.3%, p= 0.025). Inconsistent
condom use was not associated with poly drug use. Inconsis-
tent condom use was lower in IDUs with history of drug use
treatment (82.2 vs. 89.2%, p= 0.010). The association between
Table 2 | Bivariate associations between drug-related variables and
inconsistent condom use.




Own home No 478 86.9 0.002
Yes 487 80.1
Ruin No 659 81.9 0.043
Yes 306 86.7
Student house No 963 83.7 <0.001
Yes 2 25.0
Work place No 863 84.3 0.017
Yes 102 76.1
Prison No 904 82.7 0.019
Yes 61 93.8
*Chi-square.
inconsistent condom use and drug-related variables are presented
in Table 2.
Among IDUs, inconsistent condom use was associated with
having sex with multiple partners (19.1 vs. 11.7%, p= 0.001).
Inconsistent condom use was higher in IDUs who reported syringe
sharing (87.2 vs. 79.5%, p= 0.001). Inconsistent condom use was
not associated with history of lifetime non-fatal overdose, non-
fatal overdose in the past year, arrest history in the past year, or
imprisonment in the past year (p> 0.05).
Religion (p = 0.0652), Living place (p = 0.669)
Having legal income coming from a source other than a job
(p= 0.382), income through selling furniture (p= 0.766), life-
time history of tobacco smoking (p= 0.216), cigarette smoking
by parents (p= 0.937), cigarette smoking by other members of
the family (p= 0.728), drug use by parents (p= 0.139), and drug
use by members of the family (p= 0.491) were not associated
with inconsistent condom use among IDUs. Most important rea-
son for beginning drug use (p= 0.232) was not associated with
inconsistent condom use among IDUs. First person who suggested
substance (p= 0.501), first situation of drug use (p= 0.337), first
place of drug use (p= 0.467), first place of injection (p= 0.722),
first situation of first injection (p= 0.325) were not associated
with inconsistent condom use among IDUs. Cause of first injection
(p= 0.75), the person with whom the IDU injects (p= 0.143), and
frequency of injection (p= 0.70) were not associated with incon-
sistent condom use among IDUs. Common place of injection as
friends homes (p= 0.711), parks (p= 0.675), schools (p= 0.235),
street and lane (p= 0.439), and soldiers’ camps (p= 0.526) were
not associated with inconsistent condom use among IDUs.
LOGISTIC REGRESSION
Based on multivariate analysis, a higher likelihood of inconsistent
condom use was associated with history of syringe sharing; how-
ever, a lower likelihood of inconsistent condom use was associated
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0.016 0.34 0.14 0.82
Common place of
injection (home)
0.004 0.09 0.02 0.47
Syringe sharing 0.008 1.63 1.13 2.34
History of treatment 0.029 0.54 0.31 0.94
with high education level, home as usual place of injection and
history of treatment of drug disorder (Table 3).
DISCUSSION
Inconsistent condom use was reported by about 8 of 10 sexually
active male IDUs in Iran. Inconsistent condom use was higher
among IDUs who shared syringes, and among those with higher
educational level, history of drug dependence treatment, and those
who used to inject drugs inside their homes.
Literature on low rate of condom use among people who use
drugs supports our finding (34). Inconsistent condom use among
IDUs varies widely from<50% in Thailand (35) to more than 70%
in Vietnam (36) and the United States (37). One study reported
that 88% of IDUs had rarely or never used condoms during inter-
course with sex workers, and that <10% had consistently used
condoms during sexual relations with casual partners (38). Based
on another study in Iran, 19% of female sex workers reported at
least one occasion of unprotected sex with IDU(s) in the month
preceding the study (7).
Low rates of consistent condom use by IDUs may be in part due
to poor knowledge, or a consequence of sex under the influence
of drugs. Many drug users take drugs prior to intercourse which
may disturb their decision and condom use negotiation (39).
Our study showed that inconsistent use of condoms was higher
among IDUs with lower levels of education and those who usually
inject outside their homes. A link between low educational level
and inconsistent condom use has been shown in many (40–42),
but not all, studies (43). This link may be mediated by condom
use knowledge or condom use negotiation skills.
We found a link between inconsistent condom use and syringe
sharing. Similar reports have been reported from other geographic
regions (44–46). This co-occurrence may be explained by similar
risk factors and common pathways for different risky behaviors.
It is also plausible to assume that one risky behavior may facilitate
another risk taking behavior.
Our study also showed that inconsistent use of condoms was
higher among IDUs who usually inject outside their homes. In
fact, our study showed that injecting in one’s own home had the
strongest relationship to consistent condom use of all of the vari-
ables examined. For another risky behavior, which is needle and
syringe sharing among IDUs, our previous study in Iran has shown
that being alone may have some protective roles (6). In general,
characteristics such as location of drug use may be linked to a wide
range of risky behaviors. In the study by Narenjiha et al., shared
injection was linked to being alone at most injections (6).
It has been shown that a majority of IDUs may inject drugs
in their own residence (47). Injecting alone in Iran has been
reported to be associated with lower likelihood of needle sharing
(48). In one study, 15% of IDUs reported always injecting alone.
The study showed that IDUs who reported injecting alone were
substantially less likely to report injection with a syringe or other
drug preparation equipment previously used by another injector.
Authors suggested that inviting injectors to inject alone may facil-
itate safe injection by granting the individual greater control over
the injection setting (49).
Our study showed reduced inconsistent condom use among
those IDUs who had attended drug treatment centers. Literature
has both in line (50) and contradictory results (51, 52) that war-
rant further research. The link can be explained by the role of
risk reduction interventions that are in place for IDUs as a part of
treatment. Although we did not collect data on content of treat-
ment programs that our participants had entered, our finding may
reflect the effect of HIV testing or VCT programs that have a risk
reduction component.
Most IDUs are sexually active (21), and their sexual behaviors
place the community at risk for HIV/AIDS. Condom promo-
tion programs that target IDUs should be considered as a part
of HIV-AIDS prevention programs. Messages directed at IDUs
should encourage them to consistently use condoms. Although
harm reduction programs in Iran have reduced the rate of syringe
sharing (45), high risk sexual behavior of IDUs is still a threat to
the health of the nation.
Condom use offers protection against HIV/AIDS and other
sexually transmitted infections (53). It is only the consistent use
of condoms that effectively protects against HIV infection (54). As
a result, surveys should continuously monitor the rate of incon-
sistent condom use among high risk populations, including IDUs
(55).
Promotion of condom use can be achieved via different pro-
grams such as condom education and programs that increase
access to condoms (54). Programs with a condom promotion
component have proved to be effective in reducing high risk sexual
behaviors (56).
There are some limitations to this study. First, the results rely
on participants’ self-reported data which may be accompanied
by information bias, not only in the form of recall bias, but also
social desirability bias (57). Second, because of the cross-sectional
design of this study, it is not possible to draw a conclusion on
the direction of the associations. Third, this study did not ask
about condom use with different types of sexual partners. Fourth,
the study did not assess knowledge and attitude about condom
use, reasons for not using condoms, perceived need for condom
use, and availability of condoms (58). Fifth, the current study’s
response options to the outcome did not include “always or almost
always.” As a result, individuals who have reported “often” should
not be considered as “always or almost always” using condoms.
This may have also influenced the distribution of all responses to
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this outcome. This should be considered before any comparison
of the rates with other studies, as operationalization of inconsis-
tent condom use is very different in various studies. Sixth, the
main study has not provided information on the total number
of persons that were approached for an interview and how many
refused. Finally, as we tested a large number of independent vari-
ables, our study should be considered as an exploratory study.
The result is, however, relevant to the epidemic of HIV in Iran
and probably the Middle East, where such data are scant and
poor (59).
CONCLUSION
More than 8 of 10 Iranian sexually active male IDUs report incon-
sistent condom use, which reflects a serious public health threat.
Condom promotion programs in Iran should focus on IDUs who
have a lower education level, who share syringes, who inject drugs
outside their home and those with no previous treatment history.
Further research should test the efficacy of combined programs
that target both sexual and injection behavior of IDUs.
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